scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.

TL;DR: Using a combination of immunohistochemistry and reverse transcriptase-dependent in situ polymerase chain reaction analysis, monocytes expressing inducible nitric oxide synthase (iNOS) are identified to be prevalent in the plaque areas of post mortem brain tissue from patients with MS.
Journal ArticleDOI

Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier

TL;DR: The molecular weight-dependence of tumour capture of N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers was studied in vivo using subcutaneous Sarcoma 180 or B16F10 melanoma models and the ratio (accumulation index, AI) of the AUC in tumour to A UC in skeletal muscle (a typical normal tissue) increasing from six to 12 with increasing copolymer molecular weight.
Journal ArticleDOI

Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report

TL;DR: A clinical evaluation of arterial infusion of high-molecular-weight antitumor agent SMANCS dissolved in lipid lymphographic agent (thiodol) in 44 patients with mostly unresectable hepatoma demonstrated significant merits both therapeutically and diagnostically.
Journal ArticleDOI

Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.

TL;DR: Results indicate that generation of oxygen-free radicals by XO, coupled with catabolic supply of hypoxanthine from adenosine catabolism, is a pathogenic principle in influenza virus infection in mice and that a therapeutic approach by elimination of oxygen radicals thus seems possible.
Journal ArticleDOI

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers.

TL;DR: The enhanced permeability and retention (EPR) effect is a unique phenomenon of solid tumors that is related to their particular anatomical and pathophysiological characteristics, which lead to tumor tissues showing considerable extravasation of plasma components and nanomedicines.